Third Harmonic Bio Inc logo

THRD

HEALTHCARE

Third Harmonic Bio Inc

PRE

Live · NASDAQ · May 8, Close

AI Insight

What's Moving THRD Today?

No stock-specific AI insight has been generated for THRD yet. Check back soon — insights are generated from recent news analysis.

Fundamentals

Market Cap$243M
P/E Ratio
EPS$-1.24
Dividend Yield
Dividend / Share
ROE-0.2%
Profit Margin
Debt / Equity

Trading

Volume
Avg Volume (10D)
Shares Outstanding45.1M

THRD News

No news articles found for THRD yet.

Price Data

Open
Previous Close
Day High
Day Low
52 Week High$5.53
52 Week Low$5.13

About Third Harmonic Bio Inc

Third Harmonic Bio Inc. is a pioneering biotechnology firm focused on creating breakthrough therapies for severe immunology and inflammation-related disorders. Leveraging its proprietary genetic engineering platform, the company is developing a promising pipeline of drug candidates designed to meet critical unmet medical needs in the biopharmaceutical industry. With an unwavering dedication to scientific innovation and improving patient outcomes, Third Harmonic Bio is poised to significantly influence the treatment landscape, offering transformative solutions for patients enduring complex health challenges.

Listed September 14, 2022
HEALTHCAREBIOTECHNOLOGY

Company Details

Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot
SICBIOTECHNOLOGY
CIK
Composite FIGI
Share Class FIGI